Analyst Price Targets — PDS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 2, 2026 3:41 pm | Sergey Pigarev | Loop Capital Markets | $122.00 | $88.49 | StreetInsider | Precision Drilling (PDS) PT Raised to $122 at Freedom Capital Markets |
| February 17, 2026 12:01 pm | — | Piper Sandler | $105.00 | $87.35 | TheFly | Precision Drilling price target raised to $105 from $81 at Piper Sandler |
| December 18, 2025 11:29 am | — | Piper Sandler | $81.00 | $68.01 | TheFly | Precision Drilling price target raised to $81 from $79 at Piper Sandler |
| October 28, 2025 10:32 am | Derek Podhaizer | Piper Sandler | $79.00 | $59.05 | TheFly | Precision Drilling price target raised to $79 from $74 at Piper Sandler |
| July 14, 2025 8:18 pm | Derek Podhaizer | Piper Sandler | $72.00 | $49.78 | TheFly | Precision Drilling initiated with an Overweight at Piper Sandler |
| May 6, 2024 7:37 am | Luke Lemoine | Piper Sandler | $101.00 | $71.12 | StreetInsider | Precision Drilling (PDS) PT Raised to $101 at Piper Sandler |
| June 20, 2022 9:51 am | Ian Macpherson | Piper Sandler | $125.00 | $61.47 | Pulse 2.0 | Precision Drilling (PDS) Stock: $125 Target And Overweight Rating |
| January 27, 2022 12:00 am | John Bereznicki | Canaccord Genuity | $47.74 | $41.72 | StreetInsider | Canaccord Genuity Reiterates Hold Rating on Precision Drilling (PD:CN) (PDS) |
| January 7, 2022 12:00 am | James West | Evercore ISI | $65.25 | $41.30 | TipRanks Contributor | Precision Drilling (PDS) Received its Third Buy in a Row |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for PDS

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

PDS Biotechnology NASDAQ: PDSB outlined plans to advance its investigational immunocytokine PDS0301 into a Phase III study for heavily pretreated metastatic colorectal cancer with liver metastases, following discussions with the U.S. Food and Drug Administration and clinical findings from a National Cancer Institute-led study.

Shares of Precision Drilling Co. (TSE: PD - Get Free Report) (NYSE: PDS) passed above its fifty day moving average during trading on Tuesday. The stock has a fifty day moving average of C$120.13 and traded as high as C$123.16. Precision Drilling shares last traded at C$121.55, with a volume of 42,305 shares trading hands. Wall Street

Solaris Energy Infrastructure (NYSE: SEI - Get Free Report) and Precision Drilling (NYSE: PDS - Get Free Report) are both energy companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings and profitability. Earnings and Valuation This table compares Solaris

PRINCETON, N.J., Oct. 06, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced that the Company will host a virtual key opinion leader (KOL) event featuring Jonathan M.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for PDS.
Senate Trading
No Senate trades found for PDS.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
